Event JSON
{
"id": "ccde0e535fdfe8bdcba2f3dff4931a9d1255f39d4a767d9ffc4fcdde0fc44ff7",
"pubkey": "f261e77ed38c5a7c6cf34564b89b26bc002380ab3b4c2cab919e028030c393e7",
"created_at": 1735056103,
"kind": 1,
"tags": [
[
"r",
"https://www.foxnews.com/health/fda-approves-first-medication-obstructive-sleep-apnea-also-promotes-weight-loss"
],
[
"subject",
"FDA approves first medication for obstructive sleep apnea, which also promotes weight loss"
],
[
"published_at",
"1735055747"
],
[
"image",
"https://static.foxnews.com/foxnews.com/content/uploads/2024/02/iStock-629586444.jpg"
],
[
"p",
"f261e77ed38c5a7c6cf34564b89b26bc002380ab3b4c2cab919e028030c393e7",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://static.foxnews.com/foxnews.com/content/uploads/2024/02/iStock-629586444.jpg"
],
[
"t",
"conservative:perspective"
],
[
"summary",
"The FDA has approved Zepbound, a new medication for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug, developed by Eli Lilly, works by reducing appetite and food intake, and has been shown to improve OSA symptoms and reduce body weight. The FDA approval marks the first medication treatment option for certain patients with OSA. Sleep experts are hailing the approval as a promising advancement for the millions of people who suffer from sleep apnea."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7fs7wlkn33d8cm8ng4jt3xexhsqz8q9t8dxze2u3ncpgqvxrj0ns8zan0k\nhttps://static.foxnews.com/foxnews.com/content/uploads/2024/02/iStock-629586444.jpg\nThe FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.\nhttps://www.foxnews.com/health/fda-approves-first-medication-obstructive-sleep-apnea-also-promotes-weight-loss",
"sig": "d16a7f60f50aa1a0e4618076219edeec952c61cb4d2bff7c1d64bcd73bd670c66b683bc1c0993f9b2908171862f0c25a50ddbe714fc5647ad9e8c2662ccf95cf"
}
